Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

OraSure Technologies, Inc. - Common Stock (NQ:OSUR)

3.935 +0.005 (+0.13%)
Streaming Delayed Price Updated: 2:48 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 281,877
Open 3.940
Bid (Size) 3.930 (2,200)
Ask (Size) 3.940 (1,800)
Prev. Close 3.930
Today's Range 3.780 - 4.000
52wk Range 2.080 - 4.580
Shares Outstanding 73,262,370
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
OraSure (OSUR) Q2 2026 Earnings Call Transcript ↗
Revenue beat guidance at $30.6M, but IntelliQ CT/NG FDA clearance delayed to 2027. 
Via The Motley Fool
Topics Earnings
News headline image
OraSure Technologies Q2 Earnings Call Highlights ↗
OraSure Technologies (NASDAQ:OSUR) reported second-quarter revenue of $30.6 million, exceeding its guidance range and rising 9.7% sequentially, as stronger public-health diagnostics demand and growth... 
Via MarketBeat
Topics Earnings

Performance

YTD
+65.3%
+65.3%
1 Month
+4.1%
+4.1%
3 Month
-10.8%
-10.8%
6 Month
+28.2%
+28.2%
1 Year
+21.8%
+21.8%

More News

Read More
OraSure Technologies (NASDAQ:OSUR) Q2 Beat Tempered by Soft Q3 Guidance ↗
Via Chartmill
News headline image
OraSure Announces Second Quarter 2026 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
OraSure Technologies (NASDAQ:OSUR) Q1 2026 Results Meet Revenue Forecast but Losses Widen, Shares Dip ↗
Via Chartmill
OraSure Technologies Inc (NASDAQ:OSUR) Reports Mixed Q4 2025 Results Amid Strategic Transition ↗
Via Chartmill
News headline image
OraSure to Announce Second Quarter 2026 Financial Results and Host Earnings Call on August 5th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Receives Emergency Use Authorization for Second Generation Ebola Test
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Is Co-Diagnostics National Security’s Next Diagnostic Pick? ↗
Via MarketBeat
News headline image
OraSure (OSUR) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
News headline image
OraSure Announces First Quarter 2026 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance
From Altai Capital Management, L.P.
Via Business Wire
News headline image
OraSure Announces Fourth Quarter 2025 Financial Results
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Launch OraQuick™ HIV Self-Test in Canada
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
From Altai Capital Management, L.P.
Via Business Wire
News headline image
OraSure Submits CT/NG Molecular Self-Test and Colli-Pee™ Urine Collection Device for FDA Review
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
OraSure Technologies Issues Statement Regarding Altai Capital’s Intent to Nominate Director Candidates
From OraSure Technologies, Inc.
Via GlobeNewswire
News headline image
Altai Capital Management Announces Intention to Nominate Two Highly-Qualified Candidates for Election to OraSure Board of Directors
From Altai Capital Management, L.P.
Via Business Wire
News headline image
OraSure to Participate in Upcoming Investor Conference
From OraSure Technologies, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is OraSure Technologies, Inc. - Common Stock publicly traded?
Yes, OraSure Technologies, Inc. - Common Stock is publicly traded.
What exchange does OraSure Technologies, Inc. - Common Stock trade on?
OraSure Technologies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for OraSure Technologies, Inc. - Common Stock?
The ticker symbol for OraSure Technologies, Inc. - Common Stock is OSUR on the Nasdaq Stock Market
What is the current price of OraSure Technologies, Inc. - Common Stock?
The current price of OraSure Technologies, Inc. - Common Stock is 3.935
When was OraSure Technologies, Inc. - Common Stock last traded?
The last trade of OraSure Technologies, Inc. - Common Stock was at 09/25/26 02:48 PM ET
What is the market capitalization of OraSure Technologies, Inc. - Common Stock?
The market capitalization of OraSure Technologies, Inc. - Common Stock is 288.29M
How many shares of OraSure Technologies, Inc. - Common Stock are outstanding?
OraSure Technologies, Inc. - Common Stock has 288M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.